Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis.  Journal of Cystic Fibrosis.  21:e8-e10. 2022
2021 A mobile health platform for self-management of pediatric cystic fibrosis: Qualitative study of adaptation to stakeholder needs and integration in clinical settings 2021
2021 Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.  Journal of Cystic Fibrosis.  20:25-30. 2021
2020 The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.  Journal of Cystic Fibrosis.  19:868-871. 2020
2020 Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis.  Journal of Cystic Fibrosis.  19:783-790. 2020
2020 Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation.  Pediatric Pulmonology.  55:2330-2340. 2020
2020 Newborn Screening for CF across the Globe-Where Is It Worthwhile? 2020
2020 The future of cystic fibrosis care: a global perspective 2020
2016 Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.  Pediatric Pulmonology.  51:1168-1176. 2016
2015 Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes.  Pediatric Pulmonology.  50:1244-1252. 2015
2014 ESCF care guidelines beyond Europe.  Journal of Cystic Fibrosis.  13:359-360. 2014
2014 Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis.  Journal of Cystic Fibrosis.  13:593-600. 2014
2014 Sustained improvement in nutritional outcomes at two paediatric cystic fibrosis centres after quality improvement collaboratives.  BMJ Quality and Safety.  23. 2014
2011 Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor..  Annals of Pharmacotherapy.  45. 2011
2011 Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3a4 inhibitor.  Annals of Pharmacotherapy.  45. 2011
2010 Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational Cohort.  Pediatric Pulmonology.  45:934-944. 2010
2010 Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax.  American Journal of Respiratory and Critical Care Medicine.  182:298-306. 2010
2010 Improving the quality of care for patients with cystic fibrosis.  Current Opinion in Pediatrics.  22:296-301. 2010
2009 Cystic fibrosis care in Chile.  Current Opinion in Pulmonary Medicine.  15:632-637. 2009
2008 Creating a culture of improvement: experience of a pediatric cystic fibrosis center..  Journal of Nursing Care Quality.  23:115-120. 2008
2008 Genetic and reproductive knowledge among adolescents and adults with cystic fibrosis.  Chest.  133:1533. 2008
1996 Nitric oxide regulation of superoxide-dependent lung injury: Oxidant- protective actions of endogenously produced and exogenously administered nitric oxide.  Free Radical Biology and Medicine.  21:43-52. 1996
1995 Oxygen Radical-Nitric Oxide Reactions in Vascular Diseases.  Advances in Pharmacology.  34:45-69. 1995
1995 Pulmonary alveolar epithelial inducible NO synthase gene expression: Regulation by inflammatory mediators 1995
1993 Mycoplasmal infections. Epidemiology, immunology, diagnostic techniques, and therapeutic strategies.  Immunology and Allergy Clinics of North America.  13:43-57. 1993

Principal Investigator On

  • A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System  awarded by CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
  • A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test  awarded by University of Wisconsin-Madison
  • CF Center in Chile, Pilot and Feasibility Program  awarded by Cystic Fibrosis Foundation ^
  • CF Learning Network: Implementation Phase  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
  • Cystic Fibrosis Newborn Screening  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening of Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening of Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Screening of Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Cystic Fibrosis Training Network: Latin America  awarded by Cystic Fibrosis Foundation ^
  • Early Recognition and Intervention for Acute Pulmonary Exacerbation in CF  awarded by Cystic Fibrosis Foundation ^
  • I C.A.R.E. - I Change Adherence and Raise Expectations  awarded by University of Miami
  • Implementation of the Depression and Anxiety Guideline: Award for a Mental Health Coordinator  awarded by Cystic Fibrosis Foundation ^
  • Learning Network: Implementation Phase  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
  • Optimization of the Alabama CF Newborn Screening Program  awarded by Cystic Fibrosis Foundation ^
  • Pediatric Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation ^
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC.
  • The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF  awarded by CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
  • The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF  awarded by CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER
  • The Effect of Formula Fortified with Docosahexaenoic Acid (DHA) on Infants with Cystic Fibrosis  awarded by UNIVERSITY OF MASSACHUSETTS (WORCESTER)
  • Transformative Integrated Model for Continuous CF Care  awarded by Cystic Fibrosis Foundation ^
  • UAB CF Research and Translation Core Center - Pilot Supplement  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation ^
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation ^

    • Investigator On

    Education And Training

  • Pontifical Catholic University of Chile Pediatrics, Residency
  • University of Maryland Medical System Pediatrics, Residency
  • University of Alabama at Birmingham Pediatrics, Postdoctoral Fellowship
  • Doctor of Medicine, 1983

    • Full Name

  • Hector Gutierrez